SUMMARY
INTRODUCTION
Immunity to malaria is slow to develop, and although prevalence and levels of parasitaemia decrease with exposure, susceptibility to re-infection remains for years even after repeated exposure (1, 2) . This may be due to extensive antigenic variation of the parasite (3) and strain-specific immunity. However, susceptibility to repeat infections and short-lived protection from pathology may also result from inherent or malaria-specific limitations of immunological memory and protective immunity (1) . Antibodies are considered to be a major effector mechanism eliminating blood-stage malaria parasites in humans (4, 5) , and in experimental models (6,7), and it is therefore possible that impairment of protective immunity is due to defects in the B cell response. Most of our information to date on the B cell response in both human and experimental infections has come from analysis of antimalaria antibodies in sera. While there are many studies documenting the levels, isotype and duration of the antibody responses (reviewed in Ref. (8) ), there are very few cellular studies investigating the nature and development of the antibody-producing cells; B cells and plasma cells. Those studies, describing large short-lived polyclonal B cell responses (9) (10) (11) , changes in splenic microarchitecture (12) and B cell compartments such as germinal centres (13) , and deletion of malariaspecific B cells after acute infection (14) , suggest that the B cell response and resulting memory to Plasmodium may be impaired. However, Plasmodium chabaudi infection in mice does stimulate significant malaria-specific antibody responses, and we have shown that kinetics of MSP-1 specific antibody production on re-challenge are enhanced, a result compatible with the normal generation of memory B cells (15) . Studies of the nature of the plasma cell response will be important to discern reasons for the short-lived components of the antibody response to human malaria (8) .
Although the exact role for antigen, or pathogen persistence in the humoral memory response is still a matter of debate Correspondence : National Institute for Medical Research, Division of Parasitology, The Ridgeway, Mill Hill, London NW7 1AA, UK (e-mail: jlangho@nimr.mrc.ac.uk). (16 -20) , immunity appears to be enhanced in malaria and other infections by pathogen persistence (21) (22) (23) (24) , suggesting that B cell responses in malaria could be altered by chronic infection. Persistent, low-level parasitaemia following acute infection for up to 3 months is a feature of P. chabaudi infection of mice (15) , and in this respect is similar to some human infections. The chronic phase of primary infection has been shown to affect both the magnitude of the challenge infection, and the secondary antibody response (15) , and so may well have affects on the nature and magnitude of a secondary B cell response. Thus this model may provide some clues about the effects of persistent parasites on the B cell response, which could be applicable to human infection.
A detailed study of the types of B cells activated and plasma cells generated and maintained in this model may help to define the nature of the B cell response and identify populations of antibody-producing cells that are activated and maintained in infection. Therefore, in this study, we have characterized subsets of B cells and plasma cells in primary and challenge infections with Plasmodium chabaudi , and have investigated the effect of persistent infection on these subsets. We show here that previously activated B cells and plasma cells survive for 2 months after infection, even after the chronic infection has been eliminated with chloroquine. After re-challenge, in contrast to the primary infection, there is an enhanced B cell response, a greater proportion of mature plasma cells; and splenomegaly and bone marrow depletion are minimal. These data suggest that there is a more focused and efficient secondary response to the parasite, consistent with a memory response.
MATERIALS AND METHODS

Mice and parasites
C57Bl/6 mice were bred in the National Institute for Medical Research under SPF conditions and for experiments maintained conventionally with sterile food and irradiated water ad libitum . All experiments conducted under British Home Office regulations. Female 5 -8-week-old mice were infected with 10 5 parasitized erythrocytes from P. chabaudi chabaudi (AS) infected mice, and monitored by examination of Giemsa-stained blood films as described previously (25) . Chronic infection was eliminated by three i.p. injections of 50 mg chloroquine (Sigma, UK)/kg body weight (average 20 g) in 0·9% saline solution at 2-day intervals, from day 30 of infection. This clone of P. chabaudi is sensitive to chloroquine when used at low parasite density ((26) and W. Jarra, personal communication); after treatment no parasites were detectable by thin or thick blood film analysis or after sub-inoculation of blood into naïve recipients (15) . Primary and secondary infections were conducted simultaneously with age-matched uninfected controls and oldest uninfected mice are shown as day 0.
Antibodies and flow cytometric analysis
Spleens or bone marrow cells from femurs and tibias, were collected and dissociated into single cells in HBSS (Gibco, UK) containing 5% FBS (Seralabs, UK) and 6 m  HEPES. Erythrocytes were lysed using hypotonic lysis solution (Sigma). Cells were counted (Scharfe System CASY1, Reutlingen, Germany). Subset numbers were calculated by multiplying the percentage of lymphocytes by total number of viable nucleated cells.
Cells were stained at 3 × 10 6 /well in 96-well V-bottom plates and incubated with anti-CD16/32(24G2) at 37 ° C for 20 min, followed by 20 min at 4 ° C to eliminate surface binding of endogenous antibody. After washing, cells were incubated in PBS with 2% FCS and 0·01% Sodium azide and indicated combinations of FITC-, PE-, PerCP, TriColor-, biotin-or allophycocyanin-(APC)-conjugated antibodies with Strepdavidin -FITC or -APC (BD Biosciences, Cambridge Biosciences Oxford, UK). After washing, cells were fixed overnight with 2% paraformaldehyde in PBS. CD138/syndecan-1(281-2), stains were performed in PBS, 1% BSA. For intracellular staining, after surface staining, cells were fixed with PharMingen Cytofix/Cytoperm solution (BD Biosciences). Fixed cells were permeabilized by washing in Perm/Wash buffer (BD Biosciences) twice and 20-min incubation. Cells were stained with goat antimouse-IgG plus IgM-FITC (antiserum, multiply adhered, BD Biosciences) at 70 µ g/ µ L for 3 × 10 6 cells for 40 min. Cells were washed thrice in Perm/ Wash buffer and re-suspended in staining buffer. A total of 30 000 lymphocytes or 1-2 million events were collected for rare cells. Data acquired on a FACS calibur using Cell Quest Pro (Becton Dickenson) and analysed using FlowJo (Portland, OR). For all analyses, cells were first gated by forward and side scatter properties for the characteristics of lymphocytes as shown in Figure 1 (c). Plasma cell live gate includes larger cells, but not granulocytes, as some plasma cells are found near the top of the SSC scale. Stains done on different days were synchronized for analysis by equalizing gates in uninfected mice. Plasma cells gated on intracellular IgG/M were drawn after analysing surface staining. Mean fluorescence intensity of surface staining was a log lower than intracellular staining in CD138 hi CD9 + B220 − plasma cells and thus surface staining cells could be excluded.
Statistics
All experiments were analysed by one-way ANOVAs and where differences were real, individual groups were studied by Two-tailed, unpaired t -tests and P ≤ 0·05 considered significant (Prism, GraphPad San Diego, CA). 
RESULTS
Persistence of previously activated and isotype-switched memory B cells in Plasmodium chabaudi infection
The kinetics of parasitaemia and the expansion of splenocytes and B cells in a primary infection were investigated (Supplementary Figure 1 ). In order to study B cell subpopulations and plasma cells after primary P. chabaudi infection, the activation phenotype of B cells was investigated for four months following infection ( (Figure 2c ). The appearance of IgG1 + cells after IgG2a agrees with earlier observations on serum antibody kinetics in P. chabaudi infections, and coincides with the gradual increase in malaria-specific IgG1 antibodies and T helper cell precursors and the gradual decrease in IgG2a serum antibody and IFN-γ producing Th1 cells observed in this infection (30) . However, this analysis represents both malaria-specific and bystander activation of B cells.
B cells respond differently in a second infection
We next examined the phenotype of B cells after a second infection with P. chabaudi , to determine whether activation or expansion of different subpopulations took place more rapidly, as expected for a memory response. Since a primary P. chabaudi infection in C57Bl/6 can remain chronic, at very low levels, for up to 60 days, re-infection of mice in this time superimposes a second infection over the existing chronic primary infection. We therefore determined whether there was a rapid expansion of the different B cell populations, a defining characteristic of an adaptive recall response, on second challenge with P. chabaudi given to chronically infected mice and to mice treated with chloroquine after the primary infection to eliminate parasites. As described previously, both groups of mice were partially immune to the second infection, with lower secondary parasitaemias in rechallenged, chronically infected mice (15) . Although splenomegaly is dramatic in the first infection, there was only a small increase in spleen cellularity following the second infection (Figure 3a) . Furthermore, while more than 50% of bone marrow cells are mobilized out of the bone marrow at the peak of the first infection, a second infection does not seem to impact bone marrow cellularity (Figure 3b ). Figure 4d -f show this increase in B cell activation in the challenge infection using the phenotype CD38 − IgD − to identify germinal centre B cells. CD38 is down-regulated on activation and returns to normal levels on memory B cells (29) and identifies activated B cells slightly earlier than GL7. CD38 down-regulation shows a dramatic difference between the first and second infection in percent (Figure 4d ,e) and numbers ( Figure 4f ) and a dramatically increased rate of expansion can be seen in Germinal Centre B cell population in the second infection (Figure 4c,f ) . The increase in germinal centre cells in second infection was not due to increased levels of antigen, as on day 7 of a second infection, parasitaemia was one to two orders of magnitude lower than in a primary infection (15) . 
bone marrow plasma cells produced in second infection
To determine whether the increase in germinal centre and marginal zone activity corresponded with an increase in mature plasma cell production on second infection, we examined plasma cells in the spleen and bone marrow (BM) of infected mice. In agreement with our previous findings (12) , there was a large transient increase in splenic plasma cells, which expressed high levels of Syndecan-1 (CD138) as well as intracellular IgG or IgM (iIgG/M) (32) (gated as shown in Figure 6a ), in the acute phase of primary infection (Figure 6b ), peaking during acute infection and returning to levels of uninfected controls by day 60. The antibody used to detect intracellular antibody in plasma cells recognizes both IgG and IgM, however, we do not suggest that these isotypes can be expressed simultaneously. However, at day 7 of re-infection, plasma cell expansion was not observed in the spleen (Figure 6b ). Plasma cell numbers in the bone marrow show a twofold loss of CD138 hi plasma cells at the peak of infection (Figure 6c ), corresponding with overall loss of bone marrow cells. But strikingly, more bone marrow plasma cells are apparent at day 7 of the second infection than in the first. Chloroquine treatment had no significant effect on total number of plasma cells in spleen or BM at day 60 of primary infection.
In order to characterize the plasma cell subpopulations in the spleen and BM in P. chabaudi, we examined the expression of CD9 and B220 on CD138 hi , intracellular IgG/M hi plasma cells. Syndecan-1 + plasma cells can be either short-lived antibody producing cells (B220 + ), long-lived mature plasma cells (B220 − ), or their precursors (B220 + ) (33 -35) . CD9 is present on plasma cells from both T-dependent and thymus independent (TI-2) responses in C57Bl/6 mice (36).
Plasma cells in the spleen and BM, defined as CD138 hi , iIgM/IgG hi , and gated as shown in Figure 6 (a), expressed CD9; however, the proportion expressing B220 clearly differed in the two organs and throughout infection. The majority of the plasma cells in the spleen expressed B220 (68% average, day 7 Figure a,b; left panel, B220 + CD9 + gated, 0·6% of splenocytes). In the BM, B220 − plasma cells were the majority (Figure 7a ,b and 0·2% bone marrow cells). In the first infection, most plasma cells were produced in the spleen, and only B220 + plasma cells increased in numbers (Figure 7c ). Naïve mice also have a majority of B220+ plasma cells in the spleen and B220-in the bone marrow, and percentages of total plasma cells in the bone marrow do not change dramatically, due to tight constraints on the availability of niches (34) . By contrast, in the second infection there was no expansion of plasma cells in the spleen, but rather a decrease in numbers compared with uninfected controls (P = 0·01). In the bone marrow, reduction of plasma cells was much less marked upon rechallenge than in the primary (Figure 7d ). There were more mature B220 − (P = 0·0002) and total plasma cells (P = 0·03) present at day 7 of the second infection compared with the primary infection day 7 (Figure 7d) , suggesting that the primary infection generates memory B cells that produce plasma cells on re-infection. Chloroquine treatment resulted in a small but significant reduction in the number of total plasma cells (P = 0·02 t-test) as well as B220 -plasma cells in spleen on reactivation (P = 0·002 t-test), and on total (P = 0·03 t-test) but not B220 − plasma cells in the BM (Figure 7d) , confirming that the B220 − subset is not affected by antigen persistence.
DISCUSSION
Here we have shown that B cells with memory cell characteristics are generated after a single infection of the malaria parasite, P. chabaudi. These CD19 + cells do not express IgD, CD21 or CD23, though they do express CD38 indicating that they are resting memory cells (29) . These surviving cells are either IgM + or isotype switched, some expressing IgG2a + or IgG1 + . Various subsets of B cells expand rapidly on re-infection. Germinal centre B cells expand dramatically in the first week after re-infection and isotype-switched B cells expand, although cells with the phenotype of IgM + memory cells do not. Marginal Zone B cells also expand, as would be expected from a population reported to contain memory B cells. In addition, despite the large increase in immature B220 + plasma cells in the spleen in the primary infection, the second infection saw fewer of these produced. There were almost no immature, B220 + , plasma cells generated in the second infection, but an increase in bone marrow plasma cells suggests an improved response. These observations are in line with our previous work that demonstrated both faster and greater serum IgG responses to specific parasite antigens following re-infection and that serum levels of specific antibody are maintained for 8 months postinfection (15) . The plasma cells and memory-phenotype cells measured here are probably the cells responsible for the anamnestic responses measured in these antigen-specific assays.
A recent report has shown the presence of memoryphenotype B cells to day 40 post-infection (11). Our results support and extend this observation by showing that they survive day 60 post-infection. Looking at a second infection to test the functionality of memory B cells on re-stimulation, we have shown that the B cell response in the second infection has increased kinetics of activation and identified the marginal zone and the germinal centre B cells as the (Figure 4c ). Both the IgM + and IgM − memory subsets do not express CD21/35. This down-regulation of CR1/2 has also been described in P. falciparum infection (in humans, complement receptor 1). It is of interest then that haematin, a malaria parasite product, induces C3 degradation and deposition, and that its concentration correlates with surface expression of CR1 on B cells (38) . CD21 has also been reported to be down-regulated after binding to complement-coated pathogen in HIV infections (39) .
Our data shows a short-lived expansion of B220 + splenic plasma cells followed by re-population of the BM by a majority of mature B220 − plasma cells, suggesting that a fraction of the response is short-lived (35) . The bone marrow, during the acute phase of a primary infection, in contrast to the spleen, has reduced numbers of total cells and plasma cells. It has previously been reported that P. yoelli infection results in loss of bone marrow plasma cells generated by vaccination (14) . This may be as a result of apoptosis in situ, or mobilization of resident plasma cells to sites of inflammation such as the spleen (40) . In the second infection there was significantly less splenomegaly, less B cell expansion and fewer plasma cells in the spleen than during the acute primary infection. Similarly, bone marrow cellularity is not as reduced as it is in the primary response and more terminally differentiated B220 − plasma cells remained, suggesting that the large B cell response in a primary infection contained memory B cells that expanded on reinfection to produce plasma cells. It is likely that it is these cells, together with low-level re-stimulation and differentiation of memory B cells that maintain the serum antibody levels seen up to eight months in this infection (15) . Direct studies of plasma cell longevity are currently underway. This could be critical for immunity to re-infection, as BM plasma cells, having undergone significant selection, are more likely to produce the high affinity, neutralizing antibodies important for clearance of the parasite.
Throughout this study, small but significantly greater B cell responses were observed in the second infection of chronically infected mice, with more GL7 + (GC) B cells, and more BM and splenic plasma cells generated compared with drug-treated mice (Figures 4 and 7) . These differences cannot be attributed directly to parasite numbers in the second infection, as they are lower in chronically and re-infected mice (15) . Therefore, our data suggest that at some level, the presence of persistent parasites, and/or the prolonged presence of antigens from dead parasites, enhances the memory B cell compartment.
In conclusion, we have shown that the B cell response to a second infection is more efficient than the primary response, the definition of adaptive immune memory. Germinal centre B cells, marginal zone, and BM plasma cell populations increase with enhanced kinetics. The faster secondary B cell response, together with reduced splenomegaly and less overall B cell activation, suggests that the B cell response in the second infection is more focused or efficient. The next steps will be to determine whether enhanced responsiveness and changes in B cell and plasma cell phenotypes in spleen and bone marrow reflect the malaria-antigen specific response.
